PERSON – Page 7

Pfizer CEO Bourla suggests pharma tariffs will focus on US adversaries, not allies

1 month ago talkbio0Tagged Administration occupational activities, Albert, Bourla, chain concerns, Evaluation, Investments, Manufacturing, National Security, pharmaceutical tariffs, Policy, Sectioning technique, TNFRSF19 gene, Transplant Registry Unified Management Program

Pharmaceutical tariffs, Section 232 investigation, Albert Bourla, national security, trade policy, manufacturing investments, Trump administration, supply chain concerns

Octagon Therapeutics Ceases Operations Due to R&D Challenges and Unresolved Biology Questions

2 months ago talkbio0Tagged Autoimmune Diseases, B cell immunomodulator program, biology (field), Flatulence, Nordisk alliance, OCT50, Programs - Publication Format

Autoimmune disease biotech, B cell immunomodulator program, OCT50 program, Novo Nordisk alliance, Winding down operations, Unresolved biology challenges

Merck KGaA springs back into M&A game with $3.9B buyout of Pfizer spinout SpringWorks

2 months ago talkbio0Tagged disease treatments, Fibromatosis, Aggressive, Gomekli, KGaA, Merck KGaA, Neurofibromatosis 1, Ogsiveo, Pfizer, Pfizer/, pharmaceutical acquisition, SpringWorks

Pharmaceutical acquisition, rare disease treatments, Merck KGaA, SpringWorks Therapeutics, Ogsiveo, Gomekli, desmoid tumors, neurofibromatosis type 1 (NF1), Pfizer spinout

Akeso’s PD-1 inhibitor notches inaugural FDA nod for nasopharyngeal cancer

2 months ago talkbio0Tagged Akeso, Akeso 's, Anniko, Approved, Inhibitor, Nasopharyngeal carcinoma, PDCD1 gene, United States Food and Drug Administration

United States Food and Drug Administration, Approved, Akeso, Nasopharyngeal carcinoma, PDCD1 gene, Inhibitor, Akeso ‘s, Anniko

Merck KGaA closes in on SpringWorks deal at $3.5B price point

2 months ago talkbio0Tagged Acquisition (action), deal, Gomekli, Infrequent, KGaA, Merck, SpringWorks

SpringWorks, Acquisition (action), KGaA, Infrequent, Gomekli, deal, Merck

FDA puts Vyne in a twist, slapping hold on psoriasis trial over testicular toxicity concerns

2 months ago talkbio0Tagged Study on Hold, Testiculo-, Toxicity aspects, United States Food and Drug Administration, Vyne

Vyne, United States Food and Drug Administration, Testiculo-, Toxicity aspects, Study on Hold, United States Food and Drug Administration

Ex-FDA leader joins new initiative designed to fight ‘unfortunate reality’ of vaccine landscape

2 months ago talkbio0Tagged Ex-FDA, Initiative, Intact, M.D., Misinformation, Policy, Project, reality, Recommendation, threat, Vaccines

Vaccines, Project, Misinformation, Initiative, Policy, Intact, Ex-FDA, threat, Recommendation, M.D., reality

Sanofi, Novartis CEOs lambast EU price control as Trump reportedly weighs drug cost parity with other nations

2 months ago talkbio0Tagged CEOs, EU, Financial cost, Investments, Market, nations, Novartis, Parity, Pharma, Prices, sanofi, Transplant Registry Unified Management Program, U.S.

EU, Novartis, CEOs, Transplant Registry Unified Management Program, Financial cost, Parity, sanofi, Investments, Prices, Pharma, Market, nations, U.S.